To summarize, the current study demonstrated that BSP promotes MMP‐14‐dependent resistance to anoikis in human lung cancer cells by inhibiting the synthesis of miR‐150‐5p and activating the ERK signalling pathway (Figure 8). The gene discussed is IBSP; the disease is lung cancer.